These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1795514)

  • 1. Four compartment mammillary model applied to the pharmacokinetics of a spiroarsorane administered orally to rabbits.
    de Biasi J; Rekik L
    J Biomed Eng; 1991 Sep; 13(5):439-40. PubMed ID: 1795514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of two spiroarsoranes administered intravenously or orally to rabbits.
    Rekik L; Coulais Y; Rochas MA; Campistron G; Wolf JG; Houin G
    J Pharm Sci; 1989 Mar; 78(3):203-5. PubMed ID: 2724078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma kinetics of a spiroarsorane trypanocidal agent in sheep trypanosomiasis].
    Dreyfuss G; Penicaut B; Wolf JG; Dubost G; Nicolas JA
    Bull Soc Pathol Exot; 1990; 83(3):360-6. PubMed ID: 2208467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four open mammillary and catenary compartment models for pharmacokinetics studies.
    de Biasi J
    J Biomed Eng; 1989 Nov; 11(6):467-70. PubMed ID: 2811345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmental mean residence time in a mammillary model with an effect compartment after intravenous or oral administration.
    Plusquellec Y; Houin G
    J Biomed Eng; 1990 Nov; 12(6):523-6. PubMed ID: 2266749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between loading dose and infusion rate to achieve any fraction of the steady-state level in any compartment model.
    Plusquellec Y; Houin G
    J Biomed Eng; 1991 Jul; 13(4):355-9. PubMed ID: 1890832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of d(+)-usnic acid in rabbits after intravenous administration.
    Venkataramana D; Krishna DR
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):161-3. PubMed ID: 8243499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the assessment of the relative magnitude of rate constants in the linear open one-compartment model.
    Macheras P; Symillides M; Reppas C
    J Pharm Sci; 1992 Dec; 81(12):1231-3. PubMed ID: 1491348
    [No Abstract]   [Full Text] [Related]  

  • 10. Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial.
    Montes B; Catalan M; Roces A; Jeanniot JP; Honorato JM
    Eur J Clin Pharmacol; 1993; 45(2):169-72. PubMed ID: 7901024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAMCAT: an expert system for distinguishing between mammillary and catenary compartmental models.
    Kuhn de Chizelle AN; DiStefano JJ
    Comput Biol Med; 1994 May; 24(3):189-204. PubMed ID: 7924264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine.
    Evans ND; Godfrey KR; Chapman MJ; Chappell MJ; Aarons L; Duffull SB
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):93-105. PubMed ID: 11253617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of Intravenous and Oral Rolapitant: Results From a Randomized, Open-Label Pivotal Study.
    Wang X; Zhang ZY; Powers D; Wang J; Lu S; Arora S; Hughes L; Christensen J; Kansra V
    J Clin Pharmacol; 2017 Dec; 57(12):1600-1606. PubMed ID: 28906561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P-glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers.
    Wang X; Zhang ZY; Arora S; Hughes L; Wang J; Powers D; Christensen J; Lu S; Kansra V
    J Clin Pharmacol; 2018 Feb; 58(2):202-211. PubMed ID: 28906558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically relevant two-compartment pharmacokinetic models for skin.
    McCarley KD; Bunge AL
    J Pharm Sci; 2000 Sep; 89(9):1212-35. PubMed ID: 10944386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of absorption rate constant in a one-compartment model with the profile of the bioavailable dose eliminated as a function of multiples of half-life.
    Macheras P; Symillides M; Reppas C
    J Pharm Sci; 1993 Dec; 82(12):1298-300. PubMed ID: 8308718
    [No Abstract]   [Full Text] [Related]  

  • 17. A mathematical study of simple exponential modelling in biochemical processes.
    Mazumdar J; Banerjee M; Teng LY
    Australas Phys Eng Sci Med; 1991 Dec; 14(4):226-33. PubMed ID: 1789775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An interstitial compartment is necessary to link the pharmacokinetics and pharmacodynamics of mivacurium.
    Schiere S; Proost JH; Roggeveld J; Wierda M
    Eur J Anaesthesiol; 2004 Nov; 21(11):882-91. PubMed ID: 15717705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fraction of absorbed drug at the time of peak plasma concentration in an open one-compartment model after simultaneous oral and intravenous administration.
    Plusquellec Y; Houin G
    Arzneimittelforschung; 1992 Mar; 42(3):350-2. PubMed ID: 1497698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.